Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-008203
Filing Date
2019-02-07
Accepted
2019-02-07 18:06:54
Documents
2
Period of Report
2019-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7132
2 POA DOCUMENT poa.txt EX-24.3_831174 3084
  Complete submission text file 0001209191-19-008203.txt   11600
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38800 | Film No.: 19576338

Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)